This is a Validated Antibody Database (VAD) review about dog PADI2, based on 4 published articles (read how Labome selects the articles), using PADI2 antibody in all methods. It is aimed to help Labome visitors find the most suited PADI2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
PADI2 synonym: protein-arginine deiminase type-2

Proteintech Group
rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s2a
In order to elucidate how CELF1 governs the epithelial-to-mesenchymal transition, Proteintech Group PADI2 antibody (ProteinTech, 12110-1-AP) was used in western blot on human samples at 1:1000 (fig s2a). Nat Commun (2016) ncbi
rabbit polyclonal
  • western blot; human; fig 5c
In order to produce a cell culture model that reflects the heterogeneity observed in squamous cell carcinomas, Proteintech Group PADI2 antibody (Proteintech, 12110-1-AP) was used in western blot on human samples (fig 5c). Int J Cancer (2016) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse
  • western blot; mouse
Proteintech Group PADI2 antibody (ProteinTech, 12110-1-AP) was used in immunohistochemistry on mouse samples and in western blot on mouse samples . Cancer Res (2014) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; human
Proteintech Group PADI2 antibody (Proteintech, 12110-1-ap) was used in immunohistochemistry - paraffin section on human samples . PLoS Genet (2014) ncbi
Articles Reviewed
  1. Chaudhury A, Cheema S, Fachini J, Kongchan N, Lu G, Simon L, et al. CELF1 is a central node in post-transcriptional regulatory programmes underlying EMT. Nat Commun. 2016;7:13362 pubmed publisher
  2. Cantarino N, Fernández Figueras M, Valero V, Musulen E, Malinverni R, Granada I, et al. A cellular model reflecting the phenotypic heterogeneity of mutant HRAS driven squamous cell carcinoma. Int J Cancer. 2016;139:1106-16 pubmed publisher
  3. McElwee J, Mohanan S, Horibata S, Sams K, Anguish L, Mclean D, et al. PAD2 overexpression in transgenic mice promotes spontaneous skin neoplasia. Cancer Res. 2014;74:6306-17 pubmed publisher
  4. Guertin M, Zhang X, Anguish L, Kim S, Varticovski L, Lis J, et al. Targeted H3R26 deimination specifically facilitates estrogen receptor binding by modifying nucleosome structure. PLoS Genet. 2014;10:e1004613 pubmed publisher